Researchers find new target for asthma, allergy drugs

02/15/2008 | Yahoo!

Symptoms of allergic reactions may be prevented without shutting down the body's immune system by targeting the p110delta protein, which has been associated with various diseases, including cancer, a study revealed. A drug targeting the protein could be produced as a capsule for patients with asthma or as a topical medicine for eczema, and drugmakers including Genentech and Pfizer have already expressed interest in developing such a treatment, researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA